HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation.

Abstract
Peroxisome proliferator-activated receptor (PPAR)-γ is highly expressed in human and rodent placentas. Nevertheless, its function remains obscure. The present study investigated the effects of rosiglitazone, a PPAR-γ agonist, on LPS-induced fetal death. All pregnant mice except controls were intraperitoneally injected with LPS (150 μg/kg) daily from gestational day (GD)15 to GD17. As expected, maternal LPS injection caused placental inflammation and resulted in 63.6% fetal death in dams that completed the pregnancy. Interestingly, LPS-induced fetal mortality was reduced to 16.0% when pregnant mice were pretreated with RSG. Additional experiment showed that rosiglitazone pretreatment inhibited LPS-induced expressions of tumor necrosis factor (Tnf)-α, interleukin (Il)-1β, Il-6, macrophage inflammatory protein (Mip)-2 and keratinocyte-derived chemokine (Kc) in mouse placenta. Although rosiglitazone had little effect on LPS-evoked elevation of IL-10 in amniotic fluid, it alleviated LPS-evoked release of TNF-α and MIP-2 in amniotic fluid. Further analysis showed that pretreatment with rosiglitazone, which activated placental PPAR-γ signaling, simultaneously suppressed LPS-evoked nuclear factor kappa B (NF-κB) activation and blocked nuclear translocation of NF-κB p65 and p50 subunits in trophoblast giant cells of the labyrinth layer. These results provide a mechanistic explanation for PPAR-γ-mediated anti-inflammatory activity in the placentas. Overall, the present study provides additional evidence for roles of PPAR-γ as an important regulator of placental inflammation.
AuthorsQing-Li Bo, Yuan-Hua Chen, Zhen Yu, Lin Fu, Yan Zhou, Gui-Bin Zhang, Hua Wang, Zhi-Hui Zhang, De-Xiang Xu
JournalMolecular and cellular endocrinology (Mol Cell Endocrinol) Vol. 423 Pg. 51-9 (Mar 05 2016) ISSN: 1872-8057 [Electronic] Ireland
PMID26773728 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Chemokines
  • Lipopolysaccharides
  • NF-kappa B
  • PPAR gamma
  • Thiazolidinediones
  • Rosiglitazone
Topics
  • Active Transport, Cell Nucleus
  • Animals
  • Anti-Inflammatory Agents (administration & dosage)
  • Chemokines (blood)
  • Drug Evaluation, Preclinical
  • Female
  • Fetal Death (prevention & control)
  • Lipopolysaccharides (pharmacology)
  • Male
  • Mice, Inbred ICR
  • NF-kappa B (metabolism)
  • PPAR gamma (metabolism)
  • Placenta (drug effects, immunology, metabolism)
  • Pregnancy
  • Rosiglitazone
  • Signal Transduction
  • Thiazolidinediones (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: